Review Article

Management of Atrial Fibrillation in Critically Ill Patients

Table 1

Modifiable promoters of atrial fibrillation.

MechanismEtiologySpecific treatment options

Myocardial stretch (atrial hypertension, atrial dilatation, reduced contractility)Fluid overload
Acute mitral insufficiency
Mitral stenosis
Fluid removal (restrictive fluid administration, diuretics, renal replacement therapy)
Intra-aortic balloon pump; cardiac surgery
Valvuloplasty

Inappropriate oxygen delivery to the myocardium Myocardial ischemia
Hypovolemia
Anemia
Revascularization
Fluid challenge
Transfusion of red blood cells

Electrolyte disturbances (risk factors: diuretics, dialysis)Hypokalemia
Hypomagnesemia
Substitution of potassium (goal K+ 4.5–5.5 mmol/L)
Substitution of magnesium (goal Mg++ > 1.0 mmol/L)

Systemic and local inflammation Heart-lung machine
Sepsis
Myocarditis
Steroids; off-pump cardiosurgical techniques
Antimicrobial therapy
Immunosuppression

Adrenergic overstimulationInotropic support
Stress (pain, anxiety)
Reduction of inotropes
Sedation; analgesia; betablockers

Endocrine disorderElevated thyroid hormones
Pheochromocytoma
Betablockers; thyreostatic drugs
Alpha- and betablockers

VariousHypothermiaCorrection of hypothermia